Inorganic mercury pharmacokinetics in man: a hybrid model

A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period. Simulations are validated against data collected from five human subjects, and previously analyzed.In the model, two compartments simulate Hg(II) in bl...

Full description

Saved in:
Bibliographic Details
Published inXenobiotica Vol. 55; no. 1; p. 4
Main Authors Farris, Fred, Awaness, Ayda, Su, Joe
Format Journal Article
LanguageEnglish
Published England 2025
Subjects
Online AccessGet more information

Cover

Loading…
Abstract A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period. Simulations are validated against data collected from five human subjects, and previously analyzed.In the model, two compartments simulate Hg(II) in blood: one for mobile-Hg(II) and the other for immobile-Hg(II). Two corresponding compartments simulate Hg(II) in tissue. Mobile-Hg(II) represents Hg(II) available for transport across cell membranes. Immobile-Hg(II) represents Hg(II) that is not easily transported.Following dosing, blood total-Hg(II) droped rapidly in all subjects. Blood mobile-Hg(II) also droped rapidly with a concomitant rise in blood immobile-Hg(II). For four subjects, immobile-Hg(II) became the dominant Hg(II) species in blood by day 4. For subject five, mobile-Hg(II) remained dominant in blood for the study duration.Tissue mobile-Hg(II) declined rapidly for four of the subjects, with a simultaneous rapid rise in tissue immobile-Hg(II). In subject 5, tissue mobile-Hg(II) declined linearly, and immobile-Hg(II) accumulated slowly in tissue. For all subjects, tissue mobile-Hg(II) is the primary source of fecal Hg(II). The major source for Hg(II) excreted into the urine is immobile-Hg(II) from tissue.
AbstractList A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period. Simulations are validated against data collected from five human subjects, and previously analyzed.In the model, two compartments simulate Hg(II) in blood: one for mobile-Hg(II) and the other for immobile-Hg(II). Two corresponding compartments simulate Hg(II) in tissue. Mobile-Hg(II) represents Hg(II) available for transport across cell membranes. Immobile-Hg(II) represents Hg(II) that is not easily transported.Following dosing, blood total-Hg(II) droped rapidly in all subjects. Blood mobile-Hg(II) also droped rapidly with a concomitant rise in blood immobile-Hg(II). For four subjects, immobile-Hg(II) became the dominant Hg(II) species in blood by day 4. For subject five, mobile-Hg(II) remained dominant in blood for the study duration.Tissue mobile-Hg(II) declined rapidly for four of the subjects, with a simultaneous rapid rise in tissue immobile-Hg(II). In subject 5, tissue mobile-Hg(II) declined linearly, and immobile-Hg(II) accumulated slowly in tissue. For all subjects, tissue mobile-Hg(II) is the primary source of fecal Hg(II). The major source for Hg(II) excreted into the urine is immobile-Hg(II) from tissue.
Author Su, Joe
Awaness, Ayda
Farris, Fred
Author_xml – sequence: 1
  givenname: Fred
  surname: Farris
  fullname: Farris, Fred
  organization: Department of Pharmaceutical Sciences, School of Pharmacy, Westcoast University, Los Angeles, CA, USA
– sequence: 2
  givenname: Ayda
  surname: Awaness
  fullname: Awaness, Ayda
  organization: Department of Pharmaceutical Sciences, School of Pharmacy, Westcoast University, Los Angeles, CA, USA
– sequence: 3
  givenname: Joe
  surname: Su
  fullname: Su, Joe
  organization: Department of Pharmaceutical Sciences, School of Pharmacy, Westcoast University, Los Angeles, CA, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39792020$$D View this record in MEDLINE/PubMed
BookMark eNo1j8tKAzEYhYMo9qKPoOQFpv65TC7upFgtFNzouuRqo01myLSLeXsH1M05i_Nx4Fugy9KVgNAdgRUBBQ8AXCva8hUFOgXnSkt9geaECdG0mqoZWgzDFwAIQuk1mrFpn1iYI70tXf00JTmcQ3XnOuL-YGo2rvtOJZySG3AqOJvyiA0-jLYmj3Pnw_EGXUVzHMLtXy_Rx-b5ff3a7N5etuunXeNoK08NI5qryLxWjFppORXRqig8UdIL03oRqI4kBm4dsxAoRC8kY4REbkBOWkt0__vbn20Oft_XlE0d9_8O9AewjUj6
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
DOI 10.1080/00498254.2024.2448979
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
DatabaseTitleList MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Chemistry
Pharmacy, Therapeutics, & Pharmacology
EISSN 1366-5928
ExternalDocumentID 39792020
Genre Journal Article
GroupedDBID ---
.GJ
00X
03L
0R~
123
29R
36B
4.4
53G
5RE
5VS
AACCU
AALIY
AALUX
AAMIU
AAPUL
AAPXX
AAQRR
ABBKH
ABCRQ
ABDBF
ABEIZ
ABJNI
ABLIJ
ABLKL
ABUPF
ABWVI
ABXYU
ACENM
ACGEJ
ACGFS
ACIEZ
ACKYO
ACUHS
ADCVX
ADRBQ
ADXPE
ADYSH
AECIN
AEGXH
AENEX
AEOZL
AFAUU
AFKVX
AFQCT
AFRVT
AGAFX
AGDLA
AGFJD
AGRBW
AGYJP
AIJEM
AIRBT
AJEBJ
AJWEG
AJXHO
AKBVH
ALMA_UNASSIGNED_HOLDINGS
ALQZU
ALYBC
AMPGV
AOYHP
AWYRJ
BABNJ
BLEHA
BOHLJ
BVLLS
CAG
CCCUG
CGR
COF
CS3
CUY
CVF
DEIEU
DKSSO
DLVIE
DTRLO
DU5
DZHFC
EAP
EBC
EBD
EBS
EBX
ECM
EDH
EIF
EJD
EMB
EMK
EMOBN
EPL
ESX
F5P
H13
HZ~
JFOCU
KRBQP
KWAYT
KYCEM
L7B
LJTGL
M44
M4Z
MK0
NPM
NUSFT
O9-
OVD
QRXOQ
RNANH
RVRKI
SV3
TBQAZ
TEORI
TERGH
TFDNU
TFL
TFW
TUROJ
TUS
UHWXJ
V1S
ZGI
ZXP
~1N
~KM
ID FETCH-LOGICAL-c257t-31948f3d9832b7b426fb8f6d187d6a5d6e29f1fe4bc3b0e20fd673311f4a07982
IngestDate Fri May 02 01:40:58 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords pharmacokinetics, hybrid model
multicompartment model
Mercury
mercury transport
inorganic mercury
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c257t-31948f3d9832b7b426fb8f6d187d6a5d6e29f1fe4bc3b0e20fd673311f4a07982
PMID 39792020
ParticipantIDs pubmed_primary_39792020
PublicationCentury 2000
PublicationDate 2025-00-00
PublicationDateYYYYMMDD 2025-01-01
PublicationDate_xml – year: 2025
  text: 2025-00-00
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Xenobiotica
PublicationTitleAlternate Xenobiotica
PublicationYear 2025
SSID ssj0006122
Score 2.4087274
Snippet A four-compartment model is presented that simulates inorganic mercury [Hg(II)] pharmacokinetics in blood, tissue, and excreta over a 70-day period....
SourceID pubmed
SourceType Index Database
StartPage 4
SubjectTerms Adult
Humans
Male
Mercury - blood
Mercury - pharmacokinetics
Mercury - urine
Models, Biological
Tissue Distribution
Title Inorganic mercury pharmacokinetics in man: a hybrid model
URI https://www.ncbi.nlm.nih.gov/pubmed/39792020
Volume 55
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bS8MwFA5OQfciOu838iB72Sq9pJf4JsMxBWXgBnsbzQ2HrA6dSP31njTtVsfEy0soTSkl38nJOWm-7yB07jDiRCLmlssjzyKEwJxzqWMJG_Ihm0HAEWpy8t190OmT24E_KKrZ5-ySKbvgH0t5Jf9BFe4Brpol-wdkZy-FG3AN-EILCEP7K4xvElOUiTfG8oXD6DQmuRL1EwSPmQDzKNEHVA2l-THV9CxT_KYclA5kosWYpqVjO1qb0agPtItantoq3mPtGTN_ks5T-Yc3sw8vy1sIrl_aQpDG7XlBYPk0p2nnftHI537B3zg5stT1FmcVCdVJJ2TeLjSQ_FFTLKYEx2Sc4aH_KMJT9s-9C4rYRVcFVSA30MVO9Q5NvvpCxOYWTC2tob7se6povXjHQjaRRRW9LbSZpwP4ymC7jVZkUkMbraIKXw3VuwbRtIl7c6rcaxPXcXeuOp7uIDozBpwbA140BjxKMBjDJY6xMQWcmcIu6reve62OldfFsDg42Cksm5REyhMUvDELGcRYikUqEE4UiiD2RSBdqhwlCeMes6VrKxHo0pyOIrEdwnDsodXkOZEHCNuCiwhCTO4STvyQMKkUgVkbxRRCecUO0b4ZnuHEiJ8Mi4E7-rbnGFXnRnaC1hTMNnkKoduUnWVYfQKk_z4_
linkProvider National Library of Medicine
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Inorganic+mercury+pharmacokinetics+in+man%3A+a+hybrid+model&rft.jtitle=Xenobiotica&rft.au=Farris%2C+Fred&rft.au=Awaness%2C+Ayda&rft.au=Su%2C+Joe&rft.date=2025-01-01&rft.eissn=1366-5928&rft.volume=55&rft.issue=1&rft.spage=4&rft_id=info:doi/10.1080%2F00498254.2024.2448979&rft_id=info%3Apmid%2F39792020&rft_id=info%3Apmid%2F39792020&rft.externalDocID=39792020